Tamara Vervloessem

466 total citations
10 papers, 387 citations indexed

About

Tamara Vervloessem is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Tamara Vervloessem has authored 10 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Immunology and 2 papers in Genetics. Recurrent topics in Tamara Vervloessem's work include Cell death mechanisms and regulation (7 papers), Phagocytosis and Immune Regulation (4 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Tamara Vervloessem is often cited by papers focused on Cell death mechanisms and regulation (7 papers), Phagocytosis and Immune Regulation (4 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Tamara Vervloessem collaborates with scholars based in Belgium, United States and Italy. Tamara Vervloessem's co-authors include Geert Bultynck, Jan B. Parys, Humbert De Smedt, Haidar Akl, Mart Bittremieux, Santeri Kiviluoto, David I. Yule, Martijn Kerkhofs, Rita M. La Rovere and Tomas Luyten and has published in prestigious journals such as Blood, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research and Cell Death and Disease.

In The Last Decade

Tamara Vervloessem

10 papers receiving 385 citations

Peers

Tamara Vervloessem
Haidar Akl Belgium
Tamara Vervloessem
Citations per year, relative to Tamara Vervloessem Tamara Vervloessem (= 1×) peers Haidar Akl

Countries citing papers authored by Tamara Vervloessem

Since Specialization
Citations

This map shows the geographic impact of Tamara Vervloessem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamara Vervloessem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamara Vervloessem more than expected).

Fields of papers citing papers by Tamara Vervloessem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamara Vervloessem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamara Vervloessem. The network helps show where Tamara Vervloessem may publish in the future.

Co-authorship network of co-authors of Tamara Vervloessem

This figure shows the co-authorship network connecting the top 25 collaborators of Tamara Vervloessem. A scholar is included among the top collaborators of Tamara Vervloessem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamara Vervloessem. Tamara Vervloessem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kerkhofs, Martijn, Tamara Vervloessem, Tomas Luyten, et al.. (2022). The alkalinizing, lysosomotropic agent ML-9 induces a pH-dependent depletion of ER Ca2+ stores in cellulo. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1869(10). 119308–119308. 1 indexed citations
2.
Vervloessem, Tamara, Binu K. Sasi, Spyridoula Karamanou, et al.. (2020). BDA-366, a putative Bcl-2 BH4 domain antagonist, induces apoptosis independently of Bcl-2 in a variety of cancer cell models. Cell Death and Disease. 11(9). 769–769. 20 indexed citations
4.
Kerkhofs, Martijn, Tamara Vervloessem, Mart Bittremieux, & Geert Bultynck. (2019). Recent advances in uncovering the mechanisms contributing to BIRD-2-induced cell death in B-cell cancer cells. Cell Death and Disease. 10(2). 10 indexed citations
5.
Vervloessem, Tamara, et al.. (2017). Bcl-2 inhibitors as anti-cancer therapeutics: The impact of and on calcium signaling. Cell Calcium. 70. 102–116. 36 indexed citations
6.
Vervloessem, Tamara, Haidar Akl, Thomas Tousseyn, et al.. (2017). Reciprocal sensitivity of diffuse large B-cell lymphoma cells to Bcl-2 inhibitors BIRD-2 versus venetoclax. Oncotarget. 8(67). 111656–111671. 24 indexed citations
7.
Vervloessem, Tamara, Hristina Ivanova, Tomas Luyten, Jan B. Parys, & Geert Bultynck. (2016). The selective Bcl-2 inhibitor venetoclax, a BH3 mimetic, does not dysregulate intracellular Ca 2+ signaling. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1864(6). 968–976. 32 indexed citations
8.
Sasi, Binu K., Tamara Vervloessem, Stefania Gobessi, et al.. (2016). The Bcl-2 BH4 Antagonist Bda-366 Induces Apoptosis in CLL and DLBCL Cells through a Bcl-2 Independent Mechanism. Blood. 128(22). 2014–2014. 1 indexed citations
9.
Vervloessem, Tamara, David I. Yule, Geert Bultynck, & Jan B. Parys. (2014). The type 2 inositol 1,4,5-trisphosphate receptor, emerging functions for an intriguing Ca2+-release channel. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1853(9). 1992–2005. 68 indexed citations
10.
Akl, Haidar, Tamara Vervloessem, Santeri Kiviluoto, et al.. (2014). A dual role for the anti-apoptotic Bcl-2 protein in cancer: Mitochondria versus endoplasmic reticulum. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(10). 2240–2252. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026